Advertisement
WaferGen's presentation will take place at 8:00 a.m. Eastern time onWednesday, August 13, 2008. The presentation will include an overview of thecompany's SmartChip(TM) product, which is currently being developed for thegene expression and genotyping markets, and the SmartSlide(TM) product thatWaferGen is actively marketing. A live webcast and 90-day archivedpresentation can be accessed at http://www.wafergen.com.
Advertisement
About WaferGen
WaferGen Biosystems, Inc. is a leader in the development, manufacture andsale of state-of-the-art systems for gene expression, genotyping, cell biologyand stem cell research for the life science and pharmaceutical industries. Thecompany is actively developing its SmartChip(TM) product for the geneexpression and genotyping markets. SmartChip(TM) is being developed as thefirst whole genome, high throughput gene expression real-time polymerase chainreaction (PCR) platform and promises to deliver significant speed and costadvantages to researchers in the gene expression and genotyping markets.WaferGen currently markets its SmartSlide(TM) family of products to companiesand organizations involved in stem cell and cell biology research.SmartSlide(TM), which was launched in 2006, represents the first fluidicsintegrated micro-incubators enabling cell biology and stem cell research.Representative SmartSlide(TM) customers include Harvard University, MayoClinic, California Institute of Technology (CalTech), Abbott Labs, and theNational Institutes of Health (NIH).Contact: Vida Communication (on behalf of WaferGen) Stephanie Diaz (investors) Tim Brons (media) 415-675-7400 415-675-7402 [email protected] [email protected]
SOURCE WaferGen Biosystems, Inc.
